The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge
Metab Brain Dis. 2022 Dec 12;1-11. doi: 10.1007/s11011-022-01134-x.Online ahead of print.
1NewYork-Presbyterian/Weill Cornell Medical College Division of Gastroenterology and Hepatology, New York, NY, 10021, USA.
2NewYork-Presbyterian/Weill Cornell Medical College Division of Gastroenterology and Hepatology, New York, NY, 10021, USA. rur9017@med.cornell.edu.
Abstract
Hepatic Encephalopathy (HE) is a critically important complication of chronic liver disease and portal hypertension, but especially in early covert stages remains underdiagnosed and a common cause of hospitalization and morbidity. Defined by often subtle neuropsychiatric changes, significant cognitive deficits have been extensively described. While traditional methods of assessment remain underutilized in practice and subject to significant confounding with other diseases, mobile technology has emerged as a potential future tool to provide simple and dynamic cognitive assessments. This review discusses the proliferation of cognitive assessment tools, describing possible applications in encephalopathy and the challenges such an implementation may face. There are significant potential advantages to assessing cognition in real time in order to aid early detection and intervention and provide a more realistic measurement of real-world function. Despite this, there are issues with reliability, privacy, applicability and more which must be addressed prior to wide proliferation and acceptance for clinical use. Regardless, the rapid uptake of mobile technology in healthcare is likely to have significant implications for the future management of encephalopathy and liver disease at large.